Literature DB >> 7066157

Prognosis of treated hypertension 1951-1981.

C J Bulpitt.   

Abstract

1 The 5 year survival of hypertensive patients in several studies was reviewed to demonstrate the adverse effects of increasing age, being male, having a higher untreated blood pressure of severe retinal changes. 2 The decrease in survival with increase in diastolic blood pressure was not linear, mortality being relatively constant below 90 mmHg. 3 The adverse effect of severe retinal changes was independent of the untreated blood pressure. 4 In patients selected with mild hypertension, 5 year survival can exceed 97% even when untreated. 5 Owing to the lack of suitable data we cannot conclude that treatment was more effective in prolonging life in the 1970s than in previous decades. 6 In the United States non-white patients with hypertension fared worse than white patients. 7 The serum cholesterol was not positively related to mortality in treated hypertension patients. 8 Treated hypertensive patients who smoked had at least a two-fold increase in mortality over those who did not. 9 Treated patients under the age of 50 years had a four-fold increase in mortality compared with the general population. This was greater than any excess mortality observed in the elderly.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7066157      PMCID: PMC1401775          DOI: 10.1111/j.1365-2125.1982.tb01340.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  The clinical course and pathology of hypertension with papilloedema (malignant hypertension).

Authors:  P KINCAID-SMITH; J McMICHAEL; E A MURPHY
Journal:  Q J Med       Date:  1958-01

2.  The natural history and course of hypertension with papilledema (malignant hypertension).

Authors:  M F SCHOTTSTAEDT; M SOKOLOW
Journal:  Am Heart J       Date:  1953-03       Impact factor: 4.749

3.  Antihypertensive therapy in patients above age 60 years (Fourth Interim report of the European Working Party on High Blood pressure in Elderly: EWPHE).

Authors:  A Amery; P Berthaux; W Birkenhäger; A Boel; P Brixko; C Bulpitt; D Clement; F De Padua; M Deruyttere; A De Schaepdryver; C Dollery; R Fagard; F Forette; J Forte; J F Henry; J Hellemans; A Koistinen; U Laaser; P Lund-Johansen; J MacFarlane; P Miguel; A Mutsers; A Nissinen; O T Ohm; W Pelemans; A I Suchett-Kaye; J Tuomilehto; J Willems; P Willemse
Journal:  Clin Sci Mol Med Suppl       Date:  1978-12

4.  Natural history of hypertension. A case for selective non-treatment.

Authors:  J Fry
Journal:  Lancet       Date:  1974-08-24       Impact factor: 79.321

5.  Prognostic importance of ophthalmoscopic findings in essential hypertension.

Authors:  D J Breslin; R W Gifford; J F Fairbairn; T P Kearns
Journal:  JAMA       Date:  1966-01-31       Impact factor: 56.272

6.  Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure.

Authors:  I Holme; H T Waaler
Journal:  Acta Med Scand       Date:  1976

7.  Screening for hypertension: some epidemiological observations.

Authors:  W E Miall; S Chinn
Journal:  Br Med J       Date:  1974-09-07

8.  Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.

Authors:  A Helgeland
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965

9.  Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project.

Authors:  C J Bulpitt; L J Beilin; P Clifton; E C Coles; C T Dollery; J S Gear; G S Harper; B F Johnson; A D Munro-Faure
Journal:  Lancet       Date:  1979-07-21       Impact factor: 79.321

10.  Five year follow-up of effects of treatment of mild and moderate hypertension.

Authors:  J A Trafford; C R Horn; H O'Neal; R McGonigle; L Halford-Maw; R Evans
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04
View more
  3 in total

1.  "Hypertensive emergency": a useful diagnostic category.

Authors:  R B Hickler
Journal:  Am J Public Health       Date:  1988-06       Impact factor: 9.308

2.  Retinal changes in malignant hypertension.

Authors:  E McGregor; C G Isles; J L Jay; A F Lever; G D Murray
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-25

3.  Benefits from treatment and control of patients with resistant hypertension.

Authors:  Michael Doumas; Vasilios Papademetriou; Stella Douma; Charles Faselis; Konstantinos Tsioufis; Eugene Gkaliagkousi; Konstantinos Petidis; Chrysanthos Zamboulis
Journal:  Int J Hypertens       Date:  2010-12-22       Impact factor: 2.420

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.